Coherus Oncology Inc (CHRS)

Capital Expenditure

$0.00

TTM · Period ending: · USD

CHRS logo

CHRS Capital Expenditure

Latest reported$0.00
CHRS TTM CapEx (-$373.00K → $0.00)
High-resolution chart · PNG

CHRS capital expenditure history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Coherus Oncology Inc Capital Expenditure — Trailing twelve months (TTM) (USD)
Period endingCapital Expenditure (USD)
0
0
0
0
0
0
0
-34,000
-34,000
-134,000
-286,000
-339,000
-796,000
-1,576,000
-2,039,000
-2,420,000
-2,224,000
-1,759,000
-1,289,000
-1,773,000
-3,624,000
-5,593,000
-7,231,000
-6,666,000
-5,472,000
-3,270,000
-1,822,000
-1,649,000
-1,220,000
-1,043,000
-789,000
-684,000
-2,007,000
-2,963,000
-4,573,000
-8,030,000
-6,718,000
-6,058,000
-6,515,000
-4,393,000
-6,292,000
-6,999,000
-6,164,000
-5,209,000
-3,617,000
-3,902,000
-2,849,000
-2,508,000
-1,754,000
-465,000
-373,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.